BRIEF published on 10/28/2024 at 07:05, 1 year 8 months ago Palfinger AG Reports Steady Results Amid Market Challenges Financial Results Market Performance Product Launches PALFINGER AG Revenue And EBIT
BRIEF published on 10/28/2024 at 07:05, 1 year 8 months ago Palfinger AG annonce des résultats stables malgré les défis du marché Résultats Financiers Performance Du Marché PALFINGER SA Lancements De Produits Chiffre D'affaires Et EBIT
BRIEF published on 10/28/2024 at 07:03, 1 year 8 months ago OPmobility - Progression de 4,7% du chiffre d'affaires au T3 2024 Chiffre D'affaires ESG Amérique Du Nord Surperformance Marché Modules Et Exterior
BRIEF published on 10/28/2024 at 07:03, 1 year 8 months ago OPmobility Reports Q3 2024 Revenue Growth amid Market Decline ESG Rating Automotive Market OPmobility North America Growth 2024 Revenue
BRIEF published on 10/28/2024 at 05:05, 1 year 8 months ago Volatus Aerospace Announces $5 Million Brokered Private Placement Private Placement Financial News Capital Raise Brokered Offering Volatus Aerospace
BRIEF published on 10/28/2024 at 05:05, 1 year 8 months ago Volatus Aerospace annonce un placement privé par l'intermédiaire d'un courtier de 5 millions de dollars Placement Privé Actualités Financières Offre Négociée Volatus Aérospatiale Levée De Capitaux
BRIEF published on 10/27/2024 at 20:35, 1 year 8 months ago Four Nines Gold Inc. Signs Marketing Agreement with Senergy Communications Investor Awareness Marketing Partnership Senergy Communications Four Nines Gold Hayden Hill Project
BRIEF published on 10/27/2024 at 20:35, 1 year 8 months ago Four Nines Gold Inc. signe un accord de marketing avec Senergy Communications Sensibilisation Des Investisseurs Partenariat Marketing Quatre Neufs D'Or Communications Énergétiques Projet Hayden Hill
BRIEF published on 10/27/2024 at 17:20, 1 year 8 months ago Salix Pharmaceuticals Presents Xifaxan Analysis at ACG 2024 Salix Pharmaceuticals XIFAXAN Hepatic Encephalopathy ACG 2024 Plenvu
BRIEF published on 10/27/2024 at 17:20, 1 year 8 months ago Salix Pharmaceuticals présente une analyse de Xifaxan à l'ACG 2024 XIFAXAN Encéphalopathie Hépatique Produits Pharmaceutiques Salix ACG 2024 Plenvu
Published on 06/30/2026 at 09:01, 21 minutes ago Apex Mobilizes Drill Rig and Commences 2026 Exploration Program at the Cap Critical Minerals Project
Published on 06/30/2026 at 08:05, 1 hour 17 minutes ago Notice of Annual and Special Meeting of Shareholders
Published on 06/30/2026 at 05:30, 3 hours 52 minutes ago Nano One Renews At-The-Market Equity Program
Published on 06/30/2026 at 02:00, 7 hours 22 minutes ago MedMira Reports Third Quarter Results FY2026
Published on 06/30/2026 at 09:19, 3 minutes ago LION E-Mobility Accelerates the Expansion of Its BESS Business
Published on 06/30/2026 at 09:00, 22 minutes ago Removal - Zipa Precious Metals Public Limited Company
Published on 06/30/2026 at 09:00, 22 minutes ago Epitome Therapeutics Launches with €4 Million in Total Funding Following Oversubscribed Pre-Seed Round
Published on 06/30/2026 at 08:35, 47 minutes ago INSPIRED BY NINE GENERATIONS OF CURIOSITY FOR THE NATURAL WORLD, DELAMAIN INTRODUCES FOLIO NATURA, A NEW CONTEMPORARY, GENEROUSLY FRUITY EXPRESSION FROM GRANDE CHAMPAGNE
Published on 06/30/2026 at 07:30, 1 hour 52 minutes ago Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
Published on 06/30/2026 at 07:30, 1 hour 52 minutes ago Gimv cède sa participation dans AlpenBlu Clinics (précédemment Les Psy Réunis), acteur suisse des soins ambulatoires en santé mentale, à Impact Healthcare
Published on 06/30/2026 at 07:00, 2 hours 22 minutes ago bioMérieux submits 510(k) to U.S. FDA for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens
